Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
At 25, knowing what to look for in a financial advisor can set the foundation for your future. Focus on experience, fees, and communication.
21,273 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Magnite's 2025 earnings outlook centers on growing connected TV demand, platform efficiency, and navigating ad-tech p...
Peabody Energy stock 120% gains grab headlines, but what do they mean for real-world portfolios? This guide breaks do...
A midrange, budget-friendly Apple device could broaden the company’s market and boost services revenue. This guide an...
BioNTech’s stock is under pressure as investors react to weak guidance and leadership pivots. This deep dive breaks d...
The infrastructure sector kept surprising investors as new capital flowed into leading contractors. This past year sa...
Markets swing between fear and opportunity. This guide shows how to identify a growth stock dynamo before a breakout,...
As gas prices trend higher, Costco’s fuel discounts and bulk-buying model could attract more shoppers. This practical...
Investors are weighing NuScale Power as the small modular reactor (SMR) pioneer. This guide breaks down factors that ...
May presents a rare chance to own a glorious growth stock hand with enduring momentum. This guide breaks down why one...
Warren Buffett famously bailed on airlines in 2020. Now Berkshire Hathaway backs Delta with a multi-billion stake, si...
Brady Corporation has captured market attention with a rapid rally. Learn what’s driving shares brady corporation soa...